Cargando…

The influence of tumour necrosis factor α inhibitors treatment – etanercept on serum concentration of biomarkers of inflammation and cartilage turnover in psoriatic arthritis patients

INTRODUCTION: Effective treatment in psoriatic arthritis (PsA) patients can protect them from severe musculoskeletal complications. For appropriate monitoring of anti-tumour necrosis factor α (anti-TNF-α) treatment in PsA, specific biomarkers are needed. AIM: To investigate whether biological treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waszczykowski, Michał, Bednarski, Igor, Lesiak, Aleksandra, Waszczykowska, Elżbieta, Narbutt, Joanna, Fabiś, Jarosław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874864/ https://www.ncbi.nlm.nih.gov/pubmed/33603621 http://dx.doi.org/10.5114/ada.2020.96705

Ejemplares similares

Interleukin-18, interleukin-20, and matrix metalloproteinases (MMP-1, MMP-3) as markers of psoriatic arthritis disease severity and their correlations with biomarkers of inflammation and turnover of joint cartilage
por: Waszczykowski, Michał, et al.
Publicado: (2020)

Serum Biomarkers of Inflammation and Turnover of Joint Cartilage Can Help Differentiate Psoriatic Arthritis (PsA) Patients from Osteoarthritis (OA) Patients
por: Waszczykowski, Michał, et al.
Publicado: (2020)

Serum and synovial fluid concentrations of interleukin-18 and interleukin-20 in patients with osteoarthritis of the knee and their correlation with other markers of inflammation and turnover of joint cartilage
por: Waszczykowski, Michał, et al.
Publicado: (2020)

Role and effectiveness of complex and supervised rehabilitation on overall and hand function in systemic sclerosis patients—one-year follow-up study
por: Waszczykowski, Michał, et al.
Publicado: (2021)

Selective Glenohumeral external rotation deficit – sequelae of post-ORIF deltoid adhesions after treatment of the proximal humerus fracture
por: Waszczykowski, Michał, et al.
Publicado: (2020)

AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings
por: Olejniczak-Staruch, Irmina, et al.
Publicado: (2021)

The Impact of Arthroscopic Capsular Release in Patients with Primary Frozen Shoulder on Shoulder Muscular Strength
por: Waszczykowski, Michał, et al.
Publicado: (2014)

A Case of Sclerosing Mesenteritis during Etanercept Therapy for Psoriatic Arthritis
por: Bukiej, Aleksandra
Publicado: (2020)

Alterations of the Skin and Gut Microbiome in Psoriasis and Psoriatic Arthritis
por: Olejniczak-Staruch, Irmina, et al.
Publicado: (2021)

Arthroscopic-assisted Arthrodesis of the Knee Joint With the Ilizarov Technique: A Case Report and Literature Review
por: Waszczykowski, Michal, et al.
Publicado: (2016)

Etanercept-Induced Hypoglycemia in a Patient With Psoriatic Arthritis and Diabetes
por: Pfeifer, Emily C., et al.
Publicado: (2017)

The effect of an emollient with benfothiamine and Biolin prebiotic on the improvement of epidermal skin function
por: Narbutt, Joanna, et al.
Publicado: (2016)

Prospective 3-month study on the efficacy of UV-free blue light in mild psoriasis vulgaris treatment
por: Lesiak, Aleksandra, et al.
Publicado: (2021)

Circulating complexes between tumour necrosis factor‐alpha and etanercept predict long‐term efficacy of etanercept in juvenile idiopathic arthritis
por: Kahn, Robin, et al.
Publicado: (2016)

Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis
por: Kivelevitch, Dario, et al.
Publicado: (2014)

The eccentric mechanotransduction, neuro-muscular transmission, and structural reversibility of muscle fatty infiltration. An experimental advanced disuse muscle-wasting model of rabbit supraspinatus
por: Fabiś, Jarosław, et al.
Publicado: (2021)

Pyogenic Baker cyst in a patient with psoriatic arthritis during etanercept therapy
por: Wu, Keng-Yi, et al.
Publicado: (2015)

Tumour necrosis factor-α levels are elevated in adolescent patients with juvenile idiopathic arthritis on etanercept therapy
por: Radziszewska, Anna, et al.
Publicado: (2014)

Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis
por: Szeremeta, Anna, et al.
Publicado: (2023)

Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment
por: Strand, Vibeke, et al.
Publicado: (2012)

Mitogen-activated kinases in psoriatic arthritis: differences in activation and distinct regulation by etanercept therapy
por: Lories, RJU, et al.
Publicado: (2005)

Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment
por: Boggs, Robert L, et al.
Publicado: (2014)

Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review
por: Puig, Lluís, et al.
Publicado: (2019)

Comprehensive molecular and clinical analysis of adalimumab and etanercept therapeutic potential in patients with psoriatic arthritis
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2020)

NLRP1 and NLRP3 inflammasomes as a new approach to skin carcinogenesis
por: Ciążyńska, Magdalena, et al.
Publicado: (2020)

Serum cartilage oligomer proteins in psoriatic arthritis
por: Ujfalussy, I, et al.
Publicado: (2003)

Serum concentration of matrix metalloproteinases and angiogenic factors in patients with venous leg ulcers
por: Kolano, Paweł, et al.
Publicado: (2021)

Effectiveness and safety of secukinumab in patients with moderate-to-severe plaque psoriasis – a real life retrospective study
por: Galica, Katarzyna, et al.
Publicado: (2020)

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
por: Coates, Laura C, et al.
Publicado: (2020)

One week of exposure to sunlight induces progerin expression in human skin
por: Lesiak, Aleksandra, et al.
Publicado: (2017)

The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy
por: Olivieri, I., et al.
Publicado: (2008)

Psoriatic arthritis
por: Sankowski, Artur Jacek, et al.
Publicado: (2013)

Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)
por: Mease, Philip J, et al.
Publicado: (2018)

Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis—Case Series Report
por: Waszczykowska, Arleta, et al.
Publicado: (2020)

TaaI/Cdx-2 AA Variant of VDR Defines the Response to Phototherapy amongst Patients with Psoriasis
por: Lesiak, Aleksandra, et al.
Publicado: (2021)

Persistence of low disease activity after tumour necrosis factor inhibitor (TNFi) discontinuation in patients with psoriatic arthritis
por: Huynh, D H, et al.
Publicado: (2017)

Are interleukin-15 and -22 a new pathogenic factor in pustular palmoplantar psoriasis?
por: Lesiak, Aleksandra, et al.
Publicado: (2016)

Hippo Signaling Pathway as a New Potential Target in Non-Melanoma Skin Cancers: A Narrative Review
por: Bednarski, Igor Aleksander, et al.
Publicado: (2021)

GAAGs, COMP, and YKL-40 as Potential Markers of Cartilage Turnover in Blood of Children with Juvenile Idiopathic Arthritis Treated with Etanercept—Relationship with ADAMTS4, ADAMTS5, and PDGF-BB
por: Dąbkowska, Klaudia, et al.
Publicado: (2022)

Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_f1rtv0qpnpu90b2jq4kkutdbqg